Male and Female Contraceptive Development (R43/R44 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to invite SBIR applications to support and facilitate the development of new and/or improved contraceptive products for men and women.

credit:

Agency: Department of Health and Human Services

Office: National Institutes of Health

Estimated Funding: $1,500,000


Who's Eligible





Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-19-004.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-19-004.html

Contact:


Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Agency Email:


Date Posted:
2018-02-14

Application Due Date:


Archive Date:
2018-05-22



Social Entrepreneurship
Spotlight



Harvard Students Use Business for Social Good

Harvard Students Use Business for Social Good
Harvard’s Social Innovation Collaborative is preparing for its 2013 Igniting Innovation Summit on Social Entrepreneurship. The Summit is...



Jobs in the Social Sector

  Fundraising & Development Jobs
  Social Work Jobs
  Education Jobs
  Foundation Related Jobs
  Substance Abuse Jobs





More Federal Domestic Assistance Programs


National Center for Advancing Translational Sciences | State Fiscal Stabilization Fund (SFSF) Race-to-the-Top Incentive Grants, Recovery Act | Water Pollution Control State, Interstate, and Tribal Program Support | Senior Demonstration Program | Rural Housing Site Loans and Self_Help Housing Land Development Loans |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2018 Copyright Michael Saunders